Skip to content
We’ve expanded our free plan so you can explore more of Valuesider. Check out the updated pricing page to see what’s now available for free!
User

US Equity Fund CFR1 trades

Independent Franchise Partners

Independent Franchise Partners CIE FINANCIERE RICHEMON-BR A stake

total: 60

Trades details

Total transactions:
13
New positions:
1
Sold out:
1
Added:
3
Reduced:
8
Held since:
2022 Q3
Held for:
13 quarters
Latest activity:
2025 Q4
According to 2026 Q2 report, Independent Franchise Partners doesn't hold any CIE FINANCIERE RICHEMON-BR A (CFR1) shares. To date, the estimated cost basis is nearly $99.79 for "buy" trades and estimated average "sell" price is $167.67. US Equity Fund first purchased CFR1 in 2022 Q3, initially acquiring 547,324 shares. Since the initial investment in CIE FINANCIERE RICHEMON-BR A (CFR1), US Equity Fund has made 12 more transactions.

When did Independent Franchise Partners sell CIE FINANCIERE RICHEMON-BR A (CFR1)?

Independent Franchise Partners sold off the entire CIE FINANCIERE RICHEMON-BR A (CFR1) position in 2025 Q4.

When did Independent Franchise Partners buy CIE FINANCIERE RICHEMON-BR A (CFR1)?

Independent Franchise Partners first invested in CIE FINANCIERE RICHEMON-BR A (CFR1) in 2022 Q3 at the reported quarter-end price of $95.55 per share.

What's the cost basis of US Equity Fund's CFR1 stake?

The estimated cost basis for CIE FINANCIERE RICHEMON-BR A (CFR1) stake is around $99.79 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$99.79
Weighted AVG sell price:
$167.66

Independent Franchise Partners's historical trades in CIE FINANCIERE RICHEMON-BR A

13 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2025 Q4
0.00%
0
$190.44
-100% (-159,240)
-1.85%
2025 Q3
1.85%
159,240
$190.44
$30,325,713
+5.22% (+7,902)
+0.09%
2025 Q2
1.96%
151,338
$188.35
$28,505,217
+0.13% (+201)
+0%
2025 Q1
1.87%
151,137
$172.88
$26,129,088
+16.75% (+21,681)
+0.27%
2024 Q4
1.79%
129,456
$151.95
$19,670,522
-45.05% (-106,132)
-0.82%
2024 Q3
1.90%
235,588
$158.09
$37,244,254
-18.46% (-53,341)
-0.45%
2024 Q2
2.40%
288,929
$156.10
$45,102,446
-21.41% (-78,711)
-0.63%
2024 Q1
2.88%
367,640
$152.46
$56,052,004
-2.54% (-9,583)
-0.08%
2023 Q4
2.80%
377,223
$137.63
$51,915,537
-1.15% (-4,372)
-0.03%
2023 Q2
3.46%
381,595
$169.43
$64,654,356
-28.35% (-150,996)
-1.52%
2023 Q1
5.03%
$159.46
-0.20% (-1,084)
2022 Q4
4.43%
$129.67
-2.49% (-13,649)
2022 Q3
3.54%
$95.55
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.